Mid-Morning Market Update: Markets Open Higher; Nasdaq Surges Over 1%

U.S. stocks opened on a strong note this morning, with the Nasdaq Composite adding more than 1% on Tuesday.

Following the market opening Tuesday, the Dow traded up 0.84% to 34,842.67 while the NASDAQ rose 1.18% to 14,001.53. The S&P also rose, gaining, 0.82% to 4,497.84.

Also check this: Alphabet And 3 Other Stocks Sold By Insiders


Leading and Lagging Sectors


Financials shares jumped by 2.2% on Tuesday. Meanwhile, top gainers in the sector included Bakkt Holdings, Inc. BKKT, up 15% and Qudian Inc. QD up 9%.


In trading on Tuesday, energy shares fell by 1%.


Top Headline


Carnival Corporation CCL reported weaker-than-expected sales results for its first quarter on Tuesday.


Carnival posted adjusted loss of $1.66 per share, missing market expectations for a loss of $0.89 per share. The company’s quarterly sales came in at $1.62 billion, missing estimates of $2.30 billion.


Equities Trading UP


Forge Global Holdings Inc. FRGE shares shot up 89% to $19.14. True Global Ventures’ portfolio company Forge Global Holdings completed its business combination with Motive Capital Corp on the 22nd of March, 2022.


Shares of HireRight Holdings Corporation HRT got a boost, shooting 25% to $15.66 after the company reported better-than-expected Q4 results. The company also issued FY22 EPS and sales guidance above analyst estimates.


Gevo, Inc. GEVO shares were also up, gaining 17% to $5.39. Delta Air Lines signed a 75 million gallon per year agreement with Gevo.


Equities Trading DOWN

ORIC Pharmaceuticals, Inc. ORIC shares tumbled 29% to $4.77 after the company decided to discontinue the further development of ORIC-101 after interim analyses from the two Phase 1b studies, wherein ORIC-101 did not demonstrate sufficient clinical activity. Oppenheimer and Guggenheim downgraded the stock.


Shares of NeuroSense Therapeutics Ltd. NRSN were down 22% to $4.8661. NeuroSense Therapeutics shares jumped around 300% on Monday as the company received clearance from the FDA to initiate a pharmacokinetic study of PrimeC in healthy adult subjects.


Kidpik Corp. PIK was down, falling 18% to $4.72. The company recently reported a partnership with Disney for the release of Cheaper By The Dozen on Disney+.

Also check out: Executives Buy More Than $12M Of 3 Stocks


Commodities

In commodity news, oil traded down 1.6% to $110.33, while gold traded down 0.9% to $1,912.70.


Silver traded down 2.1% Tuesday to $24.775 while copper rose 0.1% to $4.7135.



Euro zone

European shares were higher today. The eurozone’s STOXX 600 gained 0.7%, London’s FTSE 100 gained 0.6%, while Spain’s IBEX 35 Index rose 0.9%. The German DAX climbed 1%, French CAC 40 rose 1.1% and Italy’s FTSE MIB Index rose 1.2%.

Construction output in the Eurozone increased 4.1% year-over-year in January, following a revised 0.2% rise in December. The UK’s government reported a £13.1 billion deficit in its public finances for the month of February.


Economics


The Richmond Fed composite manufacturing index climbed to 13 in March from 1 in the previous month.


Federal Reserve Bank of New York President John Williams is set to speak at 10:30 a.m. ET.


The Treasury will auction 52-week bills at 11:30 a.m. ET.

Check out this: Lannett And 4 Other Penny Stocks Bought By Insiders

Check out our premarket coverage here .

COVID-19 Update

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 81,448,400 cases with around 998,840 deaths. India confirmed a total of at least 43,010,970 cases and 516,570 deaths, while Brazil reported over 29,641,840 COVID-19 cases with 657,360 deaths. In total, there were at least 472,770,900 cases of COVID-19 worldwide with more than 6,106,520 deaths.

Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsPenny StocksEurozoneCommoditiesSmall CapGlobalIntraday UpdateMarketsMid-Morning Market Update
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...